type 2 diabetes with proliferative retinopathy相关文献:
Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes.
Wang H, Guo Z, Xu Y.
J Transl Med. 2022 May 13;20(1):219. doi: 10.1186/s12967-022-03425-4.
PMID:35562757
Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes.
Tesfaye H, Paik JM, Roh M, Htoo PT, Zakoul H, Schmedt N, Koeneman L, Wexler DJ, Patorno E.
JAMA Ophthalmol. 2025 Jan 1;143(1):62-71. doi: 10.1001/jamaophthalmol.2024.5219.
PMID:39636645
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes.
Orsi E, Solini A, Bonora E, Vitale M, Garofolo M, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
Diabetes Metab. 2023 Mar;49(2):101413. doi: 10.1016/j.diabet.2022.101413. Epub 2022 Nov 29.
PMID:36460217
Meta-Analysis of Diagnostic Accuracy of Retinopathy for the Detection of Diabetic Kidney Disease in Adults With Type 2 Diabetes.